结节外围T细胞淋巴瘤的过去,现在和未来的治疗方法
1Center for Lymphoid Cancer, Division of Medical Oncology BC Cancer and the University of British Columbia, British Columbia, Vancouver.
Haematologica
|December 1, 2023
概括
周围T细胞淋巴瘤 (PTCL) 是多种多样的. 目前的治疗方法,如CHOP化疗,正在以新型药物和个性化方法发展,改善结节PTCL亚型的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 包含30多种亚型,具有多样化的生物学和基因组景观.
- 节点PTCL在西方人群中很常见,在理解和治疗标准化方面存在持续的挑战.
- 目前的标准治疗包括CHOP化疗,CHP-brentuximab vedotin (BV) 在CD30+PTCL中显示出希望.
研究的目的:
- 审查当前对节点PTCL的理解和治疗进展.
- 要突出超越标准化疗的不断变化的治疗环境.
- 强调在PTCL管理中转向个性化医疗的转变.
主要方法:
- 在节点PTCL当前文献和临床实践的审查.
- 分析治疗进展,包括新药和组合疗法.
- 讨论治疗标准化方面的挑战和干细胞移植的作用.
主要成果:
- 基于CHOP的化疗仍然是一个标准,CHP-BV作为CD30+PTCL的新范式.
- 新型组合疗法正在前线和复发/耐药环境中进行研究.
- 毛囊辅助T细胞淋巴瘤对表观遗传修饰疗法表现出敏感性.
结论:
- 节点PTCL的管理正在朝着个性化的方法发展.
- 新型疗法和特定亚型的策略对于改善患者的治疗结果至关重要.
- 需要进一步的研究来解决理解的差距和标准化最佳实践.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
795
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
